Cochlear reduces earnings guidance due to coronavirus
Filed with ASX · · 2 pages · English
Story so far
Earlier from Cochlear
- 2019 Chairmans AGM Address to Shareholders
- FY19 Results ASX & Media Release
- COH - Profile Plus FDA Approval
- Cochlear announces launch of Nucleus Profile Plus implant
- COH Half Year Results Analyst - 19.02.2019
Later from Cochlear
- HY20 Result ASX & Media Release
- HY20 Result Presentation Slides
- Cochlear withdraws FY20 earnings guidance due to coronavirus
- Adverse appeal decision in the US patent infringement case
- Trading Halt
Follow Cochlear into a list and get an email when it puts out news.
Follow Cochlear